SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts

Christopher Thor Freda1, Wei Yin1, Berhane Ghebrehiwet2

  • 1Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794, United States of America.

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins trigger inflammation and thrombosis in human arterial fibroblasts. This study reveals how viral proteins impact vascular disease markers, offering insights into COVID-19 complications.

Area of Science:

  • Vascular Biology
  • Immunology
  • Virology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is linked to vascular complications, including thrombosis and inflammation.
  • Limited research exists on cellular responses to SARS-CoV-2 structural proteins in vascular cells.
  • Understanding these interactions is crucial for elucidating COVID-19's impact on vascular health.

Purpose of the Study:

  • To investigate the effects of SARS-CoV-2 structural proteins (Spike, Nucleocapsid, Membrane-Envelope) on human arterial adventitial fibroblasts.
  • To determine alterations in inflammatory, thrombotic, and diabetic disease markers following exposure to these viral proteins.
  • To hypothesize a mechanism for SARS-CoV-2-induced vascular disease progression.

Main Methods:

  • Human arterial adventitial fibroblasts were exposed to purified SARS-CoV-2 structural proteins.
  • Expression levels of specific proteins (gC1qR, ICAM-1, tissue factor, RAGE, GLUT-4) were measured.
  • Quantitative analysis was performed to assess up-regulation of target markers.

Main Results:

  • Exposure to SARS-CoV-2 proteins significantly up-regulated the expression of gC1qR, ICAM-1, tissue factor, RAGE, and GLUT-4 in adventitial fibroblasts.
  • The extent of protein expression varied depending on the specific SARS-CoV-2 protein involved.
  • These findings suggest distinct interaction mechanisms between different viral proteins and vascular cells.

Conclusions:

  • SARS-CoV-2 structural proteins can induce inflammatory and thrombotic responses in vascular cells.
  • The observed up-regulation of diabetic markers suggests a link between SARS-CoV-2 infection and metabolic dysregulation in the vasculature.
  • These cellular responses mediated by SARS-CoV-2 proteins may contribute to the altered vascular disease progression seen in COVID-19 patients.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.0K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.1K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
13.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
152